Compare CAG & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAG | BIO |
|---|---|---|
| Founded | 1919 | 1952 |
| Country | United States | United States |
| Employees | 26100 | 7450 |
| Industry | Packaged Foods | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 7.1B |
| IPO Year | 1994 | N/A |
| Metric | CAG | BIO |
|---|---|---|
| Price | $15.44 | $265.66 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 4 |
| Target Price | $19.29 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 12.4M | 237.8K |
| Earning Date | 04-01-2026 | 04-30-2026 |
| Dividend Yield | ★ 9.00% | N/A |
| EPS Growth | ★ 233.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,500,000,000.00 | N/A |
| Revenue This Year | N/A | $2.74 |
| Revenue Next Year | N/A | $3.05 |
| P/E Ratio | ★ N/A | $9.72 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.36 | $211.43 |
| 52 Week High | $27.68 | $343.12 |
| Indicator | CAG | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 27.06 | 41.30 |
| Support Level | N/A | $239.33 |
| Resistance Level | $19.54 | $289.61 |
| Average True Range (ATR) | 0.50 | 7.68 |
| MACD | -0.36 | 0.48 |
| Stochastic Oscillator | 2.28 | 24.82 |
Conagra Brands is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company primarily sells through the US retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.